Radformation has filed a notice of an exempt offering of securities to raise $7,155,196.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Radformation is raising $7,155,196.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Kurt Sysock played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Radformation
From planning and documentation to billing and beyond, Radformations user-friendly, FDA-cleared tools seamlessly integrate into your workflow to increase quality and efficiency in all stages of the treatment planning process. ClearCheck, our automated plan check and documentation software, ensures the highest quality treatment plans and helps clinics save time with 80+ plan checks and instant documentation. ClearCalc, our independent calculation software, efficiently validates plan accuracy, providing instant dose validation of photon, brachytherapy, and electron plans. EZFluence automatically generates high-quality 3D plans in just one click for any beam arrangement and any treatment site from head to toe. AutoContour, our fast and accurate automated AI contouring software, automatically segments 50 of the most commonly delineated clinical structures in seconds. ChartCheck, our treatment evaluation software, actively monitors patient data in real-time to ensure safety for ongoing treatments. QuickCode billing QA software instantly evaluates charges, automatically catching missed or incorrect codes and ensuring appropriate compensation. Save time and resources while increasing quality and safety with Radformation.
To learn more about Radformation, visit http://www.radformation.com/
Contact:
Kurt Sysock, President and Chief Executive Officer
570-329-6627
https://www.linkedin.com/in/kurt-sysock-a1ba978a/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.